May Hill Capital »

Biogen Idec shares owned by May Hill Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by May Hill Capital from 13F filings

Historical chart of May Hill Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by May Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by May Hill Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $367k 2.1k 175.99

More positions owned by May Hill Capital

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Core Msci Emkt (IEMG)
Keysight Technologies (KEYS)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for May Hill Capital

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
State Street Corporation
Wellington Management Company
Geode Capital Management
Point72 Asset Management
Norges Bank Investment Management
Susquehanna International
AQR Capital Management
Robeco Investment Management
Invesco
Barclays
Legal & General Group
Millennium Management

View all funds holding Biogen Idec